|
HS Code |
672050 |
| Generic Name | Escitalopram Oxalate |
| Brand Names | Lexapro, Cipralex |
| Drug Class | Selective Serotonin Reuptake Inhibitor (SSRI) |
| Molecular Formula | C20H21FN2O•C2H2O4 |
| Indications | Major depressive disorder, Generalized anxiety disorder |
| Dosage Forms | Tablet, Oral solution |
| Route Of Administration | Oral |
| Mechanism Of Action | Inhibits the reuptake of serotonin in the brain |
| Common Side Effects | Nausea, insomnia, dry mouth, increased sweating, fatigue |
| Half Life | Approximately 27-32 hours |
As an accredited Escitalopram Oxalate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White plastic bottle labeled "Escitalopram Oxalate Tablets, 10 mg, 100 tablets" with safety seal, manufacturer's details, and lot number. |
| Shipping | Escitalopram Oxalate is shipped in tightly sealed containers to prevent moisture and contamination, typically at controlled room temperature. Packaging complies with hazardous material regulations, including proper labeling and documentation. Handling instructions and safety data sheets accompany shipments to ensure safe transport and regulatory compliance throughout the shipping process. |
| Storage | Escitalopram Oxalate should be stored at room temperature, between 20°C to 25°C (68°F to 77°F), in a tightly closed container. Keep it away from moisture, heat, and direct light. Store in a dry, well-ventilated area, and protect from physical damage. Keep out of reach of children and incompatible materials. Follow all local, state, and federal storage guidelines for pharmaceuticals. |
|
Purity 99%: Escitalopram Oxalate with purity 99% is used in pharmaceutical formulation, where it ensures high efficacy and consistent therapeutic outcomes. Particle Size 10 microns: Escitalopram Oxalate with particle size 10 microns is used in tablet manufacturing, where it provides uniform dissolution and optimized bioavailability. Melting Point 155°C: Escitalopram Oxalate with melting point 155°C is used in solid dosage form production, where it enables stable processing and product integrity. Stability pH 7.0: Escitalopram Oxalate with stability at pH 7.0 is used in oral solution preparations, where it maintains chemical integrity and prolonged shelf life. Moisture Content ≤0.2%: Escitalopram Oxalate with moisture content ≤0.2% is used in encapsulation processes, where it minimizes hydrolytic degradation and enhances product longevity. Residue on Ignition ≤0.1%: Escitalopram Oxalate with residue on ignition ≤0.1% is used in injectable drug formulations, where it guarantees minimal impurities for patient safety. Assay ≥98.5%: Escitalopram Oxalate with assay ≥98.5% is used in active pharmaceutical ingredient synthesis, where it delivers precise dosing and reliable therapeutic action. Stability Temperature 25°C: Escitalopram Oxalate with stability temperature 25°C is used in storage and transport, where it preserves pharmacological activity under ambient conditions. |
Competitive Escitalopram Oxalate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Escitalopram Oxalate represents a significant step forward for those looking for effective support in managing depression and anxiety. In my years in healthcare journalism, I've talked to many people who live with these conditions. The struggle can hang over daily life like a heavy blanket, making normal activities feel hard and even robbing folks of their energy to connect with others. Medications like Escitalopram have turned the tide for millions, offering a path that doesn’t erase who you are, but instead quietly softens the impact of symptoms that can get in the way of work, family, and friendships.
Escitalopram Oxalate comes mainly in the form of oral tablets and solutions, designed to make daily use straightforward and practical. Most people know it as a kind of selective serotonin reuptake inhibitor, or SSRI—a type of antidepressant that works in the brain to help balance serotonin, which is the chemical that impacts mood and feelings of well-being. It's quite effective in treating major depressive disorder, and it’s also often chosen for people dealing with generalized anxiety disorder. The relief it provides doesn’t arrive overnight. Usually it takes a few weeks before individuals begin to feel its effects, and some may notice a gentle lift in mood, improvements in sleep, and a reduction in the grip of persistent worry.
The reason Escitalopram Oxalate stands out compared to other antidepressants comes down to its targeted approach and its track record of tolerability. I’ve heard from clinicians who appreciate its wide window of safety; the drug is less likely than older antidepressants to cause a burdensome set of side effects that once made treatment daunting. Anyone who has taken early-generation antidepressants knows that feeling groggy or struggling with dry mouth and weight gain became almost expected. Escitalopram delivers steady results with fewer daily annoyances for many patients. Fewer problems mean people are more likely to keep to their treatment, and long-term follow-up studies back up that trend.
On the clinical side, mental health professionals have pointed out that Escitalopram typically offers a straightforward titration schedule. Usually, people begin on a low dose, which is gradually increased based on how they're responding and how well the side effects are managed. This brings real flexibility to the process. If a teenager is struggling through a stretch of anxiety, doctors can work closely with families to find the smallest effective dose, minimizing risk. For adults with stubborn depression who’ve hit a wall with other medications, Escitalopram’s clean side-effect profile and manageable dose adjustments make it attractive as a next step.
Through interviews and conversations, I’ve met people who describe Escitalopram as a "reset button" for their daily life. One young college student explained that after months of trying to push through an unshakable fog of sadness and self-criticism, Escitalopram helped her finally get through her morning classes and pick up her guitar again. It wasn’t magic—other coping tools and therapy were still essential—but the medication gave her the mental space to start living on her own terms. On the prescribing side, doctors say the straightforward dosing and predictable effects create a sense of control, both for patients new to medication and for those shifting from older drugs.
The conversation about antidepressants often centers around side effects, effectiveness, and ease of use. Escitalopram often comes out as the preferred SSRI among psychiatrists for its relatively low occurrence of unwanted symptoms in comparison to fluoxetine, sertraline, or paroxetine. For example, weight gain, sexual side effects, or sleep disruption can derail someone's treatment journey. While no antidepressant gets entirely free of these concerns, Escitalopram is less likely to cause dramatic changes for many, thanks in part to its pure molecular structure as the active S-enantiomer, setting it apart from its older sibling citalopram. That chemical difference means fewer off-target actions, less drug-drug interaction, and more dependable outcomes in a wide variety of patients.
The active ingredient in Escitalopram Oxalate shapes its reputation. Chemically, it is the S-enantiomer of citalopram—essentially a more refined version, focusing on only the half of the molecule that does the heavy lifting on serotonin reuptake. Early drug development efforts showed that by using just the S-enantiomer, the effect on serotonin was stronger, so doctors could use less medication to get the same improvement. This translated to fewer side effects and more consistent results among different age groups and body types. From a practical angle, pharmacists can count on Escitalopram to act predictably—important for those already taking other medications or managing other health conditions.
People often ask, “How does Escitalopram compare if I’ve already tried other antidepressants?” Having witnessed friends and colleagues navigate mental health treatment for years, I’ve seen a common story unfold: folks who found their mood only slightly improved with older SSRIs, or who struggled with troubling side effects, sometimes found real relief after switching to Escitalopram. The improved tolerability isn’t just a bonus—it can mean sticking with a plan that works, rather than quitting just as progress begins. Some studies across Europe and North America show that adherence rates are meaningfully higher with Escitalopram, which translates directly to measurable improvements in quality of life, work reinforcement, and long-term health.
Any time a new medication gains popularity, people want to know how it performs among different groups. Escitalopram’s safety and effectiveness in older adults, as well as in teens, is supported by a growing body of data. Geriatric patients, who may be vulnerable to dizziness, falls, or confusion on some medicines, often handle Escitalopram well. Its clean pharmacokinetic profile—meaning how the body absorbs and breaks it down—keeps things simple for patients with other health challenges like diabetes or high blood pressure. For much younger patients, close monitoring remains critical, but pediatric psychiatrists and primary care doctors lean on Escitalopram for its solid track record. My experience in reporting has shown that thoughtful, individualized prescribing can make a lasting difference, especially for teens weathering the storm of mood disorders while juggling school, family life, and friendships.
Walking into a pharmacy and leaving with a bottle or blister pack of Escitalopram is only the midpoint of the journey. Daily use means paying attention to timing, consistency, and gradual titration. Some people take it in the morning, others at night—timing can be adjusted depending on whether it causes drowsiness or insomnia. From discussions with pharmacists, one thing shows up clearly: communication makes a difference. Patients who check in regularly with their provider tend to catch and solve problems early. This has never mattered more than in recent years, as pandemic-related anxiety and depression have pushed many into treatment for the first time in their lives. For people starting Escitalopram for the first time, the main advice is to stick with it, track changes in mood and side effects week to week, and share those details with a doctor or pharmacist at every step.
Nothing comes risk-free in medicine, and Escitalopram is no exception. Conversations often revolve around potential side effects. Nausea, headaches, dry mouth, or mild sleepiness are the most commonly reported, usually settling as the body adapts. More rarely, people experience increased anxiety at first, though this typically passes. One advantage here is the reduced likelihood of severe interactions with other drugs, which can be a game-changer for older adults with complex medication lists. Sexual side effects and changes in appetite can still show up—too often, patients hesitate to mention these topics out of embarrassment. My advice, drawn from years of reporting and the experiences of so many readers, is to bring up every concern. Doctors, nurse practitioners, and pharmacists are well-versed in troubleshooting and making adjustments that can help people stay on track.
Medications alone rarely build recovery. What’s often overlooked in official writeups is the practical wisdom drawn from people living through depression and anxiety. Escitalopram makes symptoms more manageable, lowering the wall just enough for people to pursue therapy, exercise, better sleep hygiene, and reconnection with friends and family. Many clinicians suggest pairing prescription medications with talk therapy or support groups; outcomes improve when people feel heard and supported. For those juggling jobs, family, and ongoing health concerns, a medication like Escitalopram often eases daily struggles that would otherwise steal their energy and hope. Its gentle effect smooths out what can seem like never-ending hills, letting you catch your breath before pushing ahead.
Escitalopram is now widely available in both brand-name and generic options, making it much more accessible and affordable than many newer antidepressants or branded medications. For families watching every dollar, this can be a huge relief. Insurance plans usually include Escitalopram on their formularies, and large pharmacy benefit managers count on its consistent pricing. It’s crucial to mention that for patients without insurance, discounted versions or community health plans often carry it as a standard offering, further broadening the safety net for those in need. The healthcare system still has work to do to bring mental health treatment within reach for everyone, but Escitalopram marks real progress.
Stigma still creates barriers for people even thinking about taking an antidepressant. In covering mental health stories, I’ve found that doctors hope for more honest communication about medications like Escitalopram. Many patients are worried about dependency or personality changes; in truth, SSRIs don’t create a sense of "high" or alter who you are. Instead, they quietly lift the weight, giving you a fighting chance to re-engage with life. By normalizing conversations about depression and anxiety—and the role meds like Escitalopram play in recovery—we create space for more people to seek and stick with treatment.
Escitalopram’s reliable performance opens up more options for customizing care. Research continues on how certain genetic traits impact individual responses, hinting that in years to come, doctors could better predict which patients will benefit most—minimizing the frustrating trial-and-error process that can drag out treatment. For now, routine follow-ups and check-ins remain the mainstay for spotting any problems before they grow. Healthcare teams are increasingly leveraging digital tools, such as patient portals, reminders, and telemedicine platforms, to help people stick with a treatment plan. These approaches aim to empower the patient—making the process more transparent and less overwhelming than it used to be.
As useful as Escitalopram is, mental health care still faces gaps. Many providers want to see better guidance about long-term use, withdrawal, and the subtler effects of stopping or switching medications. Some patients describe feeling stuck when they want to come off their medication or worry about relapsing if they lower their dose. More public education and better support structures could ease these transitions. There’s a need for more tailored information—written in everyday language, not medical jargon—aimed at people who face unique challenges: caregivers, young parents, or those living with chronic pain and mental health issues. Escitalopram can be part of those stories, but the best outcomes come when people can find answers they trust, speak up about concerns, and partner with their health team for the long haul.
If someone you love is starting on Escitalopram, your support can make an enormous difference. Listening without judgment, checking in regularly, and watching for subtle changes in behavior can help catch any bumps early. Sometimes, people are hesitant to speak up about feeling worse or struggling with side effects out of shame or fear of letting down their family. Honest communication goes a long way here. Drawing from personal experience, I’ve seen how families benefit from joining support groups or seeking outside help to make adjustments easier—and how much hope can come from seeing even small improvements in a loved one's day.
Medications like Escitalopram show us the power of combining science, practical knowledge, and community. Every patient brings a unique story and set of challenges, so one-size-fits-all approaches rarely hold up. Instead, the people who do best over time are those who mix up their tools—medication, counseling, exercise, rest, and connection. Health workers, counselors, and patient advocates all play their part in reinforcing this ecosystem. The growing openness around mental health means more people can try medications like Escitalopram without feeling alone or misunderstood.
The long-term story of Escitalopram Oxalate reflects everything that’s changing in psychiatry: more choices, less stigma, and a push toward treatments that fit into real life. Ongoing research keeps refining our understanding—not just of how the drug works, but also who benefits most and how we can set up care so that people keep improving month after month. Routine self-monitoring with help from phone apps or journals, plus coordinated care with a consistent provider, dramatically increases a person’s chance of achieving and holding on to recovery. In my reporting, people often say that the biggest barrier to success wasn’t the medication itself, but the silence around its use and the confusion about side effects. That’s why direct conversation, accurate information, and a culture that values mental health matter as much as the prescription itself.
Escitalopram Oxalate carries the weight of real-world experience—the trial and error of recovery, the ups and downs of daily moods, and the quiet victories that come when people find a treatment that fits. Its story stands as both a medical achievement and a symbol of hope for people facing depression and anxiety. Open, honest sharing of experiences, wider access, and continuing improvements in mental health care pave a smoother path for everyone who needs support. By understanding what Escitalopram offers, and tackling the challenges in mental health care directly, we help build a future where no one has to face these conditions without help or hope.